Stockscreener 앱 받기
0.6165
1.89%
-0.0119
전일 마감가:
$0.6284
열려 있는:
$0.621
하루 거래량:
128.23K
Relative Volume:
0.29
시가총액:
$14.34M
수익:
$56.04M
순이익/손실:
$-20.39M
주가수익비율:
-0.2527
EPS:
-2.44
순현금흐름:
$-6.84M
1주 성능:
-0.45%
1개월 성능:
-33.71%
6개월 성능:
-51.07%
1년 성능:
-23.61%
1일 변동 폭
$0.601
$0.635
1주일 범위
$0.6009
$0.6698
52주 변동 폭
$0.4677
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.6165 | 14.34M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
597.71 | 74.91B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
241.43 | 46.77B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
127.06 | 30.95B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
77.24 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.07 | 2.73B | 6.55B | 155.22M | -823.13M | 1.71 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health advances weight management device to clinical trials - MSN
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents - Yahoo Finance
Cosmos Health files patents for cancer treatments By Investing.com - Investing.com Australia
Cosmos Health advances weight management device to clinical trials By Investing.com - Investing.com South Africa
Cosmos Health Enters Final Development Phase of CCX0722 Weight M - WICZ
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - ACCESS Newswire
Cosmos Health's Novel Weight Loss Device Enters Clinical Phase, Eyes Massive $142B Market Opportunity - StockTitan
Cosmos Health files patents for cancer treatments - Investing.com India
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - ACCESS Newswire
AI Breakthrough: Cosmos Health's Dual Cancer Patents Could Revolutionize $25B Treatment Market - StockTitan
Cosmos Health Strengthens Management Team with the Appointment o - WICZ
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - ACCESS Newswire
Analyzing Ratios: Cosmos Health Inc (COSM)’s Financial Story Unveiled - The Dwinnex
Cosmos Health secures a 10-year contract with Provident - MSN
Cosmos Health Requests Appeal from the Nasdaq Stock Market - ACCESS Newswire
Cosmos Health Inc (NASDAQ: COSM) Up 32.86% From 52-Week Low; YTD Jumps 4.63% – Here’s What To Do Now - Marketing Sentinel
Cosmos Health secures a 10-year contract with Provident By Investing.com - Investing.com South Africa
Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals - AOL
Cosmos Health's Cana Labs Signs 10-Year Manufacturing Deal With Provident Pharmaceuticals - Marketscreener.com
Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility - ACCESS Newswire
Major Pharma Contract: Cosmos Health to Manufacture Generic Versions of Lioresal, Zoloft - StockTitan
Cosmos Health Inc [COSM] Shares Fall Approximately -34.36% Over the Year - Knox Daily
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar - ACCESS Newswire
Major Middle East Expansion: Cosmos Health Lands Exclusive $578K Qatar Distribution Contract - StockTitan
Cosmos Health Inc (COSM)’s stock price range in the last year - US Post News
Deeper Dive: Understanding Cosmos Health Inc (COSM) Through its Various Ratios - The Dwinnex
Cosmos Health Files Patent Application for Multiple Sclerosis Treatment -February 05, 2025 at 12:02 pm EST - Marketscreener.com
Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market - ACCESS Newswire
Revolutionary MS Treatment Patent: Cosmos Health's AI Platform Targets $26B Market - StockTitan
Cosmos health CEO Grigorios Siokas acquires $34,000 in stock - MSN
Cosmos health CEO Grigorios Siokas acquires $34,000 in stock By Investing.com - Investing.com Australia
Cosmos Health files patent for allergy inflammation treatment - MSN
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform - ACCESS Newswire
Cosmos Health : Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow - Marketscreener.com
Major European Bank Backs Cosmos Health with €2.2M Strategic Financing Deal - StockTitan
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cosmos Health Inc 주식 (COSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jan 22 '25 |
Buy |
0.77 |
38,900 |
30,000 |
4,203,689 |
| Siokas Grigorios | Chief Executive Officer |
Jan 17 '25 |
Buy |
0.86 |
29,158 |
25,000 |
4,164,789 |
| Siokas Grigorios | Chief Executive Officer |
Jan 16 '25 |
Buy |
0.83 |
47,904 |
40,000 |
4,135,631 |
| Siokas Grigorios | Chief Executive Officer |
Jan 15 '25 |
Buy |
0.80 |
62,500 |
50,000 |
4,087,727 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '25 |
Buy |
0.69 |
87,247 |
60,000 |
4,025,227 |
| Siokas Grigorios | Chief Executive Officer |
Jan 13 '25 |
Buy |
0.61 |
163,666 |
100,000 |
3,937,980 |
| Terzis Georgios | Chief Financial Officer |
Dec 20 '24 |
Buy |
0.58 |
85,778 |
50,000 |
727,263 |
| Siokas Grigorios | Chief Executive Officer |
Dec 20 '24 |
Buy |
0.58 |
257,334 |
150,000 |
3,774,314 |
1.95%
5.15%
자본화:
|
볼륨(24시간):